Entos (Now Iambic) Head of Business Development Mary Anderson Among Top 25 Healthcare Technology Leaders of San Diego for 2022
SAN DIEGO, CA – The Healthcare Technology Report has selected Mary Anderson, Senior Vice President for Business Development at Entos, for their 2022 list of Top 25 Healthcare Technology Leaders of San Diego. Anderson leads business development at Entos, Inc, as it strives to revolutionize drug discovery with a cutting-edge platform that integrates novel physics-informed AI design with high-throughput experimentation.
San Diego ranks among the “best cities for healthtech in the world, when accounting for investment, corporate infrastructure, human capital, and sector expertise. And there is certainly no shortage of innovation coming out of the city, if this list is any indication,” said The Healthcare Technology Report in its announcement of the selection. “This year’s honorees and the companies they represent are revolutionizing the healthcare technology industry.”
Joining Entos in 2021, Anderson has more than 15 years of experience in the pharmaceutical and biotech industry. Before joining Entos, she was the VP of Business Development at Turning Point. Earlier in her career, she worked for Merck KGaA as Executive Director and Head of Global Licensing and Business Development for Oncology. She earned an MBA from St. Mary’s College and an undergraduate degree in biochemistry from California Polytechnic State University – San Luis Obispo.
“Mary Anderson exemplifies the leadership, experience, and vision that we value at Entos. We could not be more pleased about her well-deserved recognition.”
- Tom Miller, Entos Co-founder and CEO
Headquartered in La Jolla, CA, the Entos team is comprised of industry leaders in machine learning, laboratory automation, and biotechnology. Entos is advancing a pipeline of small-molecule therapeutics for urgent patient need in oncology, addressing challenging targets at the pace of launch-to-clinic in two years.
“The awardees on this year’s list lead from a range of positions,” said the Healthcare Technology Report, “but what they have in common is their experienced and effective leadership in the healthcare technology space, advancing products and treatments that are measurably improving the lives of patients around the world.”
Entos is disrupting drug discovery with a cutting-edge platform that integrates novel physics-informed AI design with high-throughput experimentation. Headquartered in La Jolla, CA, the Entos team includes Nobel laureates, renowned scientists, and industry leaders in machine learning, laboratory automation, and biotechnology. Entos is advancing a pipeline of oncology therapeutics, addressing urgent patient need at the pace of program-launch-to-clinic in two years. Learn more about Entos' team, platform, and pipeline at www.entos.ai.
Sard Verbinnen & Co.